INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,216 | -26.0% | 3,201 | -12.7% | 0.00% | 0.0% |
| Q1 2023 | $136,706 | +2.7% | 3,668 | -3.8% | 0.00% | 0.0% |
| Q4 2022 | $133,070 | -44.1% | 3,814 | -8.4% | 0.00% | 0.0% |
| Q3 2022 | $238,000 | +7.2% | 4,163 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $222,000 | -39.7% | 4,361 | -13.8% | 0.00% | 0.0% |
| Q1 2022 | $368,000 | -43.8% | 5,061 | -8.6% | 0.00% | -50.0% |
| Q4 2021 | $655,000 | -20.2% | 5,539 | -9.5% | 0.00% | -33.3% |
| Q3 2021 | $821,000 | -89.9% | 6,123 | -87.8% | 0.00% | -91.4% |
| Q2 2021 | $8,097,000 | +100.9% | 50,008 | -0.4% | 0.04% | +169.2% |
| Q1 2021 | $4,030,000 | +599.7% | 50,219 | +373.9% | 0.01% | +550.0% |
| Q4 2020 | $576,000 | – | 10,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |